Influence of cell seeding density and inoculation timing on HepG2 cell engraftment on the chick chorioallantoic membrane
MethodsX · 2026-12 · 17 · 104241
DOI: 10.1016/j.mex.2026.104241 ↗Kurz gefasst
Fachartikel in der Zeitschrift MethodsX, 2026-12. Verfasst von Cristina Adriana Dehelean und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, "Victor Babeș" University of Medicine and Pharmacy Timișoara, 2 Eftimie Murgu Square, 300041, Timișoara, Romania. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Preclinical research on liver cancer requires models that closely mimic the biological environment, including three-dimensional tumor growth and vascularization, while ensuring rapid, inexpensive, and ethically favorable experimental conditions. Against this background, the chick embryo chorioallantoic membrane (CAM) offers a highly vascularized, immunologically immature (not yet immunocompetent) in ovo environment favorable for the engraftment of human tumor cells and in accordance with the 3R principles. HepG2 is the most widely used human hepatic tumor cell line, and although it is recognized as a malignant hepatic tumor, its precise classification remains debated. In this article, two cell densities (0.5 × 10⁶ and 1 × 10⁶ cells) were compared at three engraftment times (embryonic day 7, 8, and 9) to define reproducible engraftment conditions. Cohesive, histologically processable grafts were obtained only at the highest cell density, grafted on day 9, with a success rate of 85% (17/20 eggs). The five remaining conditions yielded no processable graft (0/100). Hematoxylin-eosin staining showed a cellular mass on the membrane, whereas the immunohistochemical panel (HepPar-1, Arginase-1, pan-cytokeratin) showed focal, heterogeneous staining. Therefore, the findings are compatible with a malignant hepatocellular tumor. The protocol is reported together with the five unsuccessful conditions as a practical reference for laboratories setting up the assay.•Cell density and grafting day determine cohesive HepG2 graft formation on the CAM.•Grafts formed only with 1 × 10⁶ cells on embryonic day 9 (17/20); others 0/100.•Five suboptimal conditions are reported as a CAM assay troubleshooting reference.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Pharmacy, "Victor Babeș" University of Medicine and Pharmacy Timișoara, 2 Eftimie Murgu Square, 300041, Timișoara, Romania.
- Research Center for Pharmaco-Toxicological Evaluations (FARMATOX), "Victor Babeș" University of Medicine and Pharmacy Timișoara, 2 Eftimie Murgu Square, 300041, Timișoara, Romania.
- Faculty of Medicine, "Victor Babeș" University of Medicine and Pharmacy Timișoara, 2 Eftimie Murgu Square, 300041, Timișoara, Romania.
- ANAPATMOL Research Center, Faculty of Medicine, "Victor Babeș" University of Medicine and Pharmacy Timișoara, 2 Eftimie Murgu Square, 300041, Timișoara, Romania.
Zitieren
APA
Dehelean, C. A., Ali, D. H., Barna, R., Predescu, I., & Macasoi, I. (2026). Influence of cell seeding density and inoculation timing on HepG2 cell engraftment on the chick chorioallantoic membrane. MethodsX, 17, 104241. https://doi.org/10.1016/j.mex.2026.104241
Vancouver
Dehelean CA, Ali DH, Barna R, Predescu I, Macasoi I. Influence of cell seeding density and inoculation timing on HepG2 cell engraftment on the chick chorioallantoic membrane. MethodsX. 2026;17:104241. doi:10.1016/j.mex.2026.104241
BibTeX
@article{Dehelean2026,
author = {Dehelean, Cristina Adriana and Ali, Diana Haj and Barna, Robert and Predescu, Iasmina and Macasoi, Ioana},
title = {Influence of cell seeding density and inoculation timing on HepG2 cell engraftment on the chick chorioallantoic membrane},
journal = {MethodsX},
year = {2026},
volume = {17},
pages = {104241},
doi = {10.1016/j.mex.2026.104241}
}
EUVIMED